An innovative and remarkable biosensor platform developed for cancer prognosis has been reported by Elshafey et al., where gold nanoparticles provide large surface area for p53 protein modification and reduced graphene oxide is used for signal enrichment [88]. Here, TP53 is linked to cancer.